3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 15.91
-0.15 (-0.93%)
Jun 26, 2026, 4:08 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 39.79 billion as of June 26, 2026. Its market cap has decreased by -14.13% in one year.
Market Cap
39.79B
Enterprise Value
24.09B
Revenue
19.69B
Ranking
n/a
PE Ratio
4.17
Stock Price
15.91
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 39.79B, an increase of 75.51%. That is a compound annual growth rate of 5.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 39.79B | -34.12% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 97.47B |
| Akeso | 76.73B |
| Sino Biopharmaceutical | 75.95B |
| RemeGen | 60.56B |
| Biocytogen Pharmaceuticals (Beijing) | 40.18B |
| Shanghai Junshi Biosciences | 30.20B |
| Shanghai Henlius Biotech | 30.16B |
| Genscript Biotech | 25.80B |